Detalhe da pesquisa
1.
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
Blood
; 142(12): 1056-1070, 2023 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339579
2.
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.
Int J Mol Sci
; 25(2)2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279277
3.
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer.
Int J Mol Sci
; 24(4)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835335
4.
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer.
Gastroenterology
; 161(1): 196-210, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745946
5.
GSK3ß regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Breast Cancer Res
; 21(1): 37, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30845991
6.
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo.
PLoS One
; 18(3): e0281063, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952536
7.
Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas.
Cancer Metab
; 10(1): 6, 2022 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193687
8.
Screening of GPCR drugs for repurposing in breast cancer.
Front Pharmacol
; 13: 1049640, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36561339
9.
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models.
Mol Cancer Ther
; 20(12): 2352-2361, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34583979
10.
Author Correction: Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns.
Sci Rep
; 10(1): 19101, 2020 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127998
11.
Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns.
Sci Rep
; 10(1): 3199, 2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32081928
12.
Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma.
Oncotarget
; 8(50): 87455-87471, 2017 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29152094
13.
Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy.
Sci Rep
; 5: 9850, 2015 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25984967
14.
A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer.
J Thorac Oncol
; 9(7): 965-973, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24922006
15.
Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasis.
J Biomol Screen
; 17(5): 572-80, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22357874